Global Ophthalmology Therapeutics Market 2019-2023
SKU ID : TNV-14098797 | Publishing Date : 27-Mar-2019 | No. of pages : 133
Detailed TOC of Global Ophthalmology Therapeutics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Retinal disorder therapeutics - Market size and forecast 2018-2023
• Glaucoma therapeutics - Market size and forecast 2018-2023
• Dry eye syndrome therapeutics - Market size and forecast 2018-2023
• Eye infections and inflammation therapeutics - Market size
• and forecast 2018-2023
• Other therapeutics - Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Market trends
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Regeneron Pharmaceuticals, Inc.
• Santen Pharmaceutical Co., Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: Retinal disorder therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Retinal disorder therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 21: Glaucoma therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Glaucoma therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 23: Dry eye syndrome therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Dry eye syndrome therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 25: Eye infections and inflammation therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Eye infections and inflammation therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 27: Other therapeutics - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Other therapeutics - Year-over-year growth 2019-2023 (%)
Exhibit 29: Market opportunity by product
Exhibit 30: Customer landscape
Exhibit 31: Market share by geography 2018-2023 (%)
Exhibit 32: Geographic comparison
Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Late-stage pipeline drugs
Exhibit 44: Patent expiry
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Mergers and acquisitions in 2017 and 2018
Exhibit 47: Gene therapies under development
Exhibit 48: Vendor landscape
Exhibit 49: Landscape disruption
Exhibit 50: Vendors covered
Exhibit 51: Vendor classification
Exhibit 52: Market positioning of vendors
Exhibit 53: ALLERGAN - Vendor overview
Exhibit 54: ALLERGAN - Business segments
Exhibit 55: ALLERGAN - Organizational developments
Exhibit 56: ALLERGAN - Geographic focus
Exhibit 57: ALLERGAN - Segment focus
Exhibit 58: ALLERGAN - Key offerings
Exhibit 59: F. Hoffmann-La Roche Ltd - Vendor overview
Exhibit 60: F. Hoffmann-La Roche Ltd - Business segments
Exhibit 61: F. Hoffmann-La Roche Ltd - Organizational developments
Exhibit 62: F. Hoffmann-La Roche Ltd - Geographic focus
Exhibit 63: F. Hoffmann-La Roche Ltd - Segment focus
Exhibit 64: F. Hoffmann-La Roche Ltd - Key offerings
Exhibit 65: Novartis AG - Vendor overview
Exhibit 66: Novartis AG - Business segments
Exhibit 67: Novartis AG - Organizational developments
Exhibit 68: Novartis AG - Geographic focus
Exhibit 69: Novartis AG - Segment focus
Exhibit 70: Novartis AG - Key offerings
Exhibit 71: Regeneron Pharmaceuticals, Inc. - Vendor overview
Exhibit 72: Regeneron Pharmaceuticals, Inc. - Business segments
Exhibit 73: Regeneron Pharmaceuticals, Inc. - Organizational developments
Exhibit 74: Regeneron Pharmaceuticals, Inc. - Key offerings
Exhibit 75: Santen Pharmaceutical Co., Ltd. - Vendor overview
Exhibit 76: Santen Pharmaceutical Co., Ltd. - Business segments
Exhibit 77: Santen Pharmaceutical Co., Ltd. - Organizational developments
Exhibit 78: Santen Pharmaceutical Co., Ltd. - Geographic focus
Exhibit 79: Santen Pharmaceutical Co., Ltd. - Key offerings
Exhibit 80: Validation techniques employed for market sizing
Keyplayers in Global Ophthalmology Therapeutics Market 2019-2023
ALLERGAN,F. Hoffmann-La Roche Ltd
Novartis AG
Regeneron Pharmaceuticals Inc
Santen Pharmaceutical Co., Ltd.